Skip to content

DE · 88Q.DE

4basebio PLC

Programmatic access: valuation JSON for this ticker · catalog · agent briefing · agent card. Paid lookups: HTTP 402 then Payment-Authorization, or Authorization: Bearer ic_live_….

Sector
Healthcare · Biotechnology
Headquarters
Cambridge

Price · as of 2026-09-07

$5.65

Market cap 81.3M

Price history

The price history chart is shown only to users with a Pro subscription.

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for 4basebio PLC (88Q.DE) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

The valuation history chart is shown only to users with a Pro subscription.

Historic valuation ratios

Pick a category, then toggle metrics to compare.

Historic valuation ratios are shown only to users with a Pro subscription.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About 4basebio PLC

        4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.

        CEO
        Amy Jo Walker
        Employees
        101
        Beta
        0.87

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.